These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 210929)
1. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins. Cho-chung YS; Doud FJ Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929 [TBL] [Abstract][Full Text] [Related]
2. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy. Bodwin JS; Clair T; Cho-Chung YS Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938 [TBL] [Abstract][Full Text] [Related]
3. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events. Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577 [TBL] [Abstract][Full Text] [Related]
4. Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy. Cho-Chung YS; Redler BH; Lewallen RP Cancer Res; 1978 Oct; 38(10):3405-9. PubMed ID: 210937 [No Abstract] [Full Text] [Related]
5. Cyclic AMP receptor triggers nuclear protein phosphorylation in a hormone-dependent mammary tumor cell-free system. Cho-Chung YS; Archibald D; Clair T Science; 1979 Sep; 205(4413):1390-2. PubMed ID: 224463 [TBL] [Abstract][Full Text] [Related]
6. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control. Cho-Chung YS Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186 [No Abstract] [Full Text] [Related]
7. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300 [TBL] [Abstract][Full Text] [Related]
8. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression. Lee C J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705 [TBL] [Abstract][Full Text] [Related]
9. Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors. Foecking MK; Abou-Issa H; Webb TE; Minton JP J Natl Cancer Inst; 1983 Oct; 71(4):773-8. PubMed ID: 6312151 [TBL] [Abstract][Full Text] [Related]
10. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase. Cho-Chung YS; Clair T; Shepheard C Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567 [TBL] [Abstract][Full Text] [Related]
11. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479 [TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclic adenosine 3',5'-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in rats. Ip C; Dao TL Cancer Lett; 1980 Jan; 8(3):227-33. PubMed ID: 6261941 [TBL] [Abstract][Full Text] [Related]
13. Relationship of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats. Matusik RJ; Hilf R J Natl Cancer Inst; 1976 Mar; 56(3):659-61. PubMed ID: 176403 [TBL] [Abstract][Full Text] [Related]
14. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats. Smith RD; Hilf R; Senior AE Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605 [TBL] [Abstract][Full Text] [Related]
16. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Verdeal K; Brown RR; Richardson T; Ryan DS J Natl Cancer Inst; 1980 Feb; 64(2):285-90. PubMed ID: 6766510 [TBL] [Abstract][Full Text] [Related]
17. Specific stimulation by estradiol of tissue-type plasminogen activator production in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells. Yamashita J; Inada K; Yamashita S; Matsuo S; Nakashima Y; Ogawa M Horm Metab Res; 1992 Dec; 24(12):565-9. PubMed ID: 1478614 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomas. Ogreid D; Cho-Chung YS; Ekanger R; Vintermyr O; Haavik J; Døskeland SO Cancer Res; 1987 May; 47(10):2576-82. PubMed ID: 3032409 [TBL] [Abstract][Full Text] [Related]
19. Effect of catechol estrogens on rat mammary tumors. Abul-Hajj YJ Cancer Res; 1979 Dec; 39(12):4882-6. PubMed ID: 115583 [TBL] [Abstract][Full Text] [Related]
20. Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat. Ip C; Ip MM J Natl Cancer Inst; 1981 Feb; 66(2):291-5. PubMed ID: 6779045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]